| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 7Developing evidence | 100.0% (7/7) | 42.9% (3/7) | -0.8% | +0.6% | -11.6% |
| 20D | 7Developing evidence | 100.0% (7/7) | 28.6% (2/7) | -10.5% | -7.8% | -17.0% |
| 60D | 7Developing evidence | 100.0% (7/7) | 28.6% (2/7) | -29.2% | -11.6% | -40.8% |
| 120D | 5Developing evidence | 100.0% (5/5) | 0.0% (0/5) | -56.3% | -56.5% | -59.4% |
COMPANY RESEARCH
IRLAB Therapeutics AB
IRLAB-A.ST · Sweden · Healthcare · Biotechnology
INSIDER SIGNAL
Insider activity score：65.8 / 100
9 insiders · 13 purchase events · €365k net purchases
Europe #154 · Sweden #32
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
Cluster+35.0 / 35
How many distinct insiders bought in the cluster
Purchase size+20.8 / 25
Purchase value relative to company size and liquidity
Role+20.0 / 20
The seniority and relevance of participating insiders
Recency+0.0 / 10
How recently the purchases occurred
Conviction+10.0 / 10
How clearly buying stands out from other activity
What is holding the score back?
- ⚠ Purchase activity is becoming less recent
- ✓ Broad buyer cluster · 4+ distinct filers
- ✓ Strong insider role · ceo/chair involved
The role contribution uses the inverted role input of the current European model.
Buying concentration
Not worked out: the scoring window holds no qualifying purchase filing, or the purchases are reported in more than one currency.
This is a ranking under the current European screening rules—not a probability of gain, return forecast, or buy recommendation.
Key purchase quotes (filing currency)
| Filer | Price per unit | Trade date |
|---|---|---|
| James Gamgort | 0.14 USD | Jul 8, 2026 |
| James Gamgort | 0.15 USD | Jul 7, 2026 |
| Joakim Tedroff | 1.2 SEK | Jul 1, 2026 |
Model details
Cluster breakdown (does not change the score)
- 15-day buyer breadth (count)
- 9 distinct reported filers
- Peak time window
- 2026-06-26 to 2026-07-08
- Current breadth input
- 1.000 (capped at 4+ buyers)
- Buyer independence
- Not yet measured; related-party fields are not cross-market comparable
What the filings show
- 🟢 Recent eligible purchase
James Gamgort · 1k USD · Price 0.14 USD · Jul 8, 2026 - 🟢 Eligible purchase
James Gamgort · 30k USD · Price 0.15 USD · Jul 7, 2026 - 🟢 Large eligible purchase
Joakim Tedroff · 4.82m SEK · Price 1.2 SEK · Jul 1, 2026 - 🟡 13 remaining qualified transaction line(s) across 13 disclosure(s)
Insider vs stock price
6 purchase day(s), 16 purchase line(s) in the 180-day window.
Daily close (SEK)Day with an insider purchaseTwo or more insiders the same day
Markers sit on the closing price of the transaction day. They show when insiders traded, not the price they paid or received. "Since" compares that day's close with the last close shown; it is what happened at this company, not a forecast.
If you had followed the purchase
Each row starts on the first close on or after the day a purchase was made public, the earliest a reader could have acted, and ends on the last close shown above.
| Made public | Insiders | In this stock, now | In the median peer stock, now | Difference |
|---|---|---|---|---|
| 2026-06-26 | 3 | 1,548 +54.8% | 961 −3.9% | +586 +58.6 pts |
| 2026-06-29 | 1 | 1,573 +57.3% | 971 −2.9% | +603 +60.3 pts |
| 2026-07-01 | 1 | 1,520 +52.0% | 965 −3.5% | +555 +55.5 pts |
| 2026-07-02 | 2 | 1,437 +43.7% | 957 −4.3% | +479 +47.9 pts |
| 2026-07-03 | 2 | 1,464 +46.4% | 942 −5.8% | +522 +52.2 pts |
| 2026-07-06 | 1 | 1,441 +44.1% | 970 −3.0% | +471 +47.1 pts |
| 2026-07-09 | 1 | 1,370 +37.0% | 976 −2.4% | +394 +39.4 pts |
7 of 7 disclosure day(s) ended ahead of the median peer stock.
Close to close, before costs, taxes, dividends and currency moves. The peer is the median of the other stocks on the same exchange for which this site holds prices (98 here), not an index. This is what happened, not a forecast: across all purchases on this site the typical gap is close to zero.
Insider timeline
9 insiders bought within 13 days, 26 Jun to 8 Jul: 6 Board member, 2 CEO / chair, 1 CFO. The share closed at 1.22 on the first of those days and at 1.89 most recently (+54.8%). That week 185 companies across Europe disclosed insider purchases, an ordinary week (12 of the last 26).
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
▮Purple band: several insiders bought within 15 days
The band marks the stretch with the most different buyers: at most 15 days long and at least two people. Here it is 26 Jun – 8 Jul, with 9 insiders. Only the strongest stretch is marked. Several people deciding the same thing is harder to explain by one person's private reasons, but insiders often buy together just after a closed period ends, so compare it with the grey weekly bars.
Blue line: this share's price, +24.2% over these six months
The closing price of each day, from 1.52 on 2026-04-21 to 1.89 on 2026-10-14. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, −9.2%
Taken from the 457 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share +24.2%, the typical one −9.2%, 33.4 points ahead. It is not an index and not a comparison within one industry.
▂Grey bars: companies across Europe disclosing purchases each week
A taller bar is a week in which more companies disclosed insider purchases. The purple bar is the week of the band above: 185 companies, number 12 of the last 26 weeks. If that week was a peak anyway, buying together is less special than it looks.
This company: insiders buying per month, last 12 months
1Nov
Dec
Jan
Feb
Mar
Apr
May
5Jun
7Jul
Aug
Sep
Oct
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since | Earlier purchases |
|---|---|---|---|---|---|---|---|
| Kristina Torfgård | CEO / chair | 2 | — | 300.0k SEK | 2026-06-26 | +54.8% | fewer than 5 completed |
| Carola Elisabet Lemne | CEO / chair | 2 | — | 100.0k SEK | 2026-06-30 | +52.3% | fewer than 5 completed |
| Gustaf Albèrt | CFO | 1 | — | 360.0k SEK | 2026-07-03 | +46.4% | fewer than 5 completed |
| Borkholmen Invest AB | Board member | 1 | — | 512.9k SEK | 2026-06-26 | +54.8% | fewer than 5 completed |
| Joakim Tedroff | Board member | 2 | — | 5.5M SEK | 2026-06-26 | +54.8% | 7 completed, median −29.2% against peers after 60 sessions |
| Nicholas Waters | Board member | 1 | — | 300.0k SEK | 2026-06-26 | +54.8% | fewer than 5 completed |
| Jan-Fredrik Backman | Board member | 1 | — | 250.0k SEK | 2026-07-03 | +46.4% | fewer than 5 completed |
| Jan-Fredrik Wilhelm Backman | Board member | 1 | — | 200.0k SEK | 2026-07-03 | +46.4% | fewer than 5 completed |
| James Gamgort | Board member | 2 | — | 31.5k USD | 2026-07-07 | +35.4% | fewer than 5 completed |
Why this score? · Model details
Priority = 100 × Σ(fixed weight × 0–1 rule-based input)
| Factor | Weight | This company input | Point contribution |
|---|---|---|---|
| 15-day buyer breadth (count) | 35% | 1.000 | 35.0 |
| Qualified-buy size | 25% | 0.830 | 20.8 |
| Role informativeness (inverted) | 20% | 0.000 | 0.0 |
| Recency | 10% | 0.001 | 0.0 |
| Buy/sell conviction | 10% | 1.000 | 10.0 |
This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.
BULL VS BEAR
Two readings of this buying
The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.
Since 2026-10-13, neither column has changed. All bull and bear lists, and what followed each line in the past →
Where the evidence comes from
Independent evidence does not object: the purchases themselves carry bull lines (more buyers than usual here, senior executive buying); share price and trading, short sellers were checked and none crosses a bear threshold. No data is held for: company results.
- The insider purchases themselvesBullmore buyers than usual here, senior executive buying Bearlatest purchase is old, buyer's past purchases trailed the benchmark3 checked, under the threshold · 1 missing
- Share price and tradingBearthinly traded2 checked, under the threshold
- Short sellers1 checked, under the threshold
- Company results2 missing
- Company actionsBearsubscription to new shares
Bull case · the buying is informative
- 9 insiders bought in the last 180 days against 1 in the 180 days before: more than this company's own recent norm.Record: after 3,134 earlier disclosures like this, the median 60-session excess return was −2.7%, within 1 percentage point of all comparable disclosures (−2.7%).
- The buyers include the CEO or chair, who sees more of the business than most filers. This site's score gives little or no credit for that: in its backtests purchases by senior executives did no better than other insiders' purchases.Record: after 8,797 earlier disclosures like this, the median 60-session excess return was −3.1%, within 1 percentage point of all comparable disclosures (−3.2%).
Bear case · discount it
- Company actions14 of 16 purchase lines are subscriptions to newly issued shares (“Teckning”), bought from the company at an issue price and not in the market. Insiders often take part to support a financing.
- The latest purchase was 101 days ago (2026-07-08). A reporting period has passed since, so what the buyers knew then may already be public.
- The 7 earlier purchases by Joakim Tedroff trailed OMX Stockholm 30 by a median 29% over the following 60 trading days.
- Share price and tradingAbout €112k of the stock changes hands on an average day, below this site's €500k screening line. A position is hard to enter or leave at the quoted price.
Evidence still missing
- The company's market value is not captured, so the purchases cannot be stated as a share of the business.
- No earnings, margin or cash-flow figures are captured for this company. The latest annual and interim reports are where to check whether the business is improving or deteriorating.
- The filings give the size of each trade, not what the buyer already held. Whether a purchase added 1% to a personal stake or doubled it is not known.
Checked and under the threshold: 6
- BullAt most 1 insider bought within any 15 days. Counted for the bull side from 3.
- Bear2 of 9 buyers filed as a person closely associated with a manager. Counted for the bear side from half.
- BearNo insider sale is recorded in the same 180 days.
- BearThe share price changed +24% over six months (three months +47%, one month +3.1%) and stands 35% below its 52-week high. Counted for the bear side from a fall of 20%.
- BearOver three months the share price changed +47% and the median of 271 Healthcare companies changed −6.3%: ahead by 53 points. Counted for the bear side from 20 points behind.
- BearThe register of Finansinspektionen shows no published net short position in this company. Positions under 0.5% are never published, so this does not show that nobody is short.
Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.
Signal history
65.8 / 100
Latest recorded score
→ +0.0 ptsversus the comparable snapshot on 2026-09-14 (34 calendar days apart)
- Recorded snapshots
- 35
- First snapshot
- 2026-08-26
Only scores captured when the scoring run completed are compared. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.
Why did it change?
Decomposition across the five score factors between comparable snapshots; historical scores are not recalculated.
- Recency-0.1 pts
Signal score history
Fixed 0–100 scale; dates are spaced by calendar time.
Recent recorded points
- 66.7
- 65.9
- 65.8
- 65.8
- 65.8
View all recorded scores
| Snapshot date | Signal score |
|---|---|
| 2026-08-26 | 66.7 |
| 2026-08-27 | 66.7 |
| 2026-08-28 | 66.1 |
| 2026-08-31 | 66.0 |
| 2026-09-01 | 66.0 |
| 2026-09-02 | 66.0 |
| 2026-09-03 | 65.9 |
| 2026-09-04 | 65.9 |
| 2026-09-07 | 65.9 |
| 2026-09-08 | 65.9 |
| 2026-09-09 | 65.9 |
| 2026-09-10 | 65.9 |
| 2026-09-11 | 65.9 |
| 2026-09-14 | 65.8 |
| 2026-09-23 | 65.8 |
| 2026-09-24 | 65.8 |
| 2026-09-25 | 65.8 |
| 2026-09-28 | 65.8 |
| 2026-09-29 | 65.8 |
| 2026-09-30 | 65.8 |
| 2026-10-01 | 65.8 |
| 2026-10-02 | 65.8 |
| 2026-10-03 | 65.8 |
| 2026-10-04 | 65.8 |
| 2026-10-05 | 65.8 |
| 2026-10-06 | 65.8 |
| 2026-10-07 | 65.8 |
| 2026-10-08 | 65.8 |
| 2026-10-09 | 65.8 |
| 2026-10-12 | 65.8 |
| 2026-10-13 | 65.8 |
| 2026-10-14 | 65.8 |
| 2026-10-15 | 65.8 |
| 2026-10-16 | 65.8 |
| 2026-10-18 | 65.8 |
Sector context
- Buying breadth
- 6.1% (48 / 792 issuers)
- Sector rank
- #11 / 12
- 7D breadth change
- -0.4 pp · vs 2026-10-12 (6d)
- 30D breadth change
- History building
This is sector-level research context. It does not affect the Insider Signal or ranking.
Insider profile outcomes
Historical performance following insider filings. The company role is translated below each name while preserving the original title.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = completed events with positive excess return ÷ total completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
- Small-sample rule: n<5 is shown for transparency and is not scored.
Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 3Small sample | 100.0% (3/3) | 66.7% (2/3) | +5.6% | +3.2% | -1.6% |
| 20D | 3Small sample | 100.0% (3/3) | 0.0% (0/3) | -1.6% | -3.0% | -5.7% |
| 60D | 3Small sample | 100.0% (3/3) | 66.7% (2/3) | +37.2% | +15.6% | -27.7% |
| 120D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -55.4% | -55.4% | -55.4% |
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 3Small sample | 100.0% (3/3) | 66.7% (2/3) | +2.8% | +2.2% | -1.9% |
| 20D | 3Small sample | 100.0% (3/3) | 33.3% (1/3) | -1.6% | -2.8% | -9.3% |
| 60D | 3Small sample | 100.0% (3/3) | 66.7% (2/3) | +37.2% | +14.9% | -30.4% |
| 120D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -57.0% | -57.0% | -57.0% |
Market context
PRICE PERFORMANCE
VOLATILITY & LIQUIDITY
- Volatility
- 85.9%
- Beta
- —
- Avg daily volume
- SEK 2.0M
VALUATION
- Market cap
- —
- P/E
- —
FUNDAMENTALS
- Profit margin
- -87.8%
- ROE
- -254.7%
- Industry
- —
Prices to 15 Oct 2026: OpenBB/yfinance; volume from price cache (yfinance). From the company's annual report ↗, fiscal year ended 31 Dec 2024: Profit margin, ROE. It does not affect the insider score or rank.
Disclosed net short positions
The Finansinspektionen register, read 18 Oct 2026, publishes no net short position of 0.5% or more in this issuer. Positions below 0.5% are never published, so this is not evidence that nobody is short.
Short-position disclosures are external context; they do not affect the insider score, ranking, or filing eligibility.
Insiders' buying price vs the latest close
Insiders paid 1.20 SEK a share on average (11 purchase lines, 8 buyers, 2026-06-26 – 2026-07-03). The close on 2026-10-14 was 57.3% above that price.
The latest purchase (2026-07-03) was at 1.20 SEK; the close was 57.3% above that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Buying size vs market trading
0.00% · of estimated traded value in the same period
2026-09-17 – 2026-10-14 · 20 recorded trading sessions
- Disclosed qualifying purchases
- 0 SEK
- Estimated market traded value
- 24,934,474 SEK
Market-data coverage: 503 verified sessions · Latest session: 2026-10-14 · Ratio status: Available
Recent and largest purchase events / preceding 60-session ADTV
- Jul 03 · Gustaf Albèrt · Ekonomichef/finanschef/finansdirektör243,157 SEK · 79.05%307,603 SEK ADTV
- Jul 03 · Jan-Fredrik Backman · Styrelseledamot168,859 SEK · 54.90%307,603 SEK ADTV
- Jul 03 · Jan-Fredrik Wilhelm Backman · Styrelseledamot135,088 SEK · 43.92%307,603 SEK ADTV
- Jul 01 · Carola Elisabet Lemne · Styrelseordförande37,200 SEK · 13.21%281,595 SEK ADTV
- Jul 01 · Joakim Tedroff · Annan medlem i bolagets administrations-, lednings- eller kontrollorgan4,820,090 SEK · 1711.71%281,595 SEK ADTV
- Jul 01 · Kristina Torfgård · Verkställande direktör (VD)220,630 SEK · 78.35%281,595 SEK ADTV
- Jun 30 · Carola Elisabet Lemne · Styrelseordförande62,800 SEK · 23.82%263,598 SEK ADTV
- Jun 26 · Joakim Tedroff · Annan medlem i bolagets administrations-, lednings- eller kontrollorgan667,010 SEK · 254.83%261,749 SEK ADTV
Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.
Latest news
No news has been captured for this company.
Regulatory filings
The filing records held for this company carry no link to the original notice.
Filing evidence
These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.
Excluded transactions & classification
19 qualifying purchase disclosure(s) · 19 transaction line(s)
Jul 8, 2026Förvärv
James Gamgort · Styrelseledamot
Aktie · 10500.0 shares × 0.14 USD · —
Jul 7, 2026Förvärv
James Gamgort · Styrelseledamot
Aktie · 200000.0 shares × 0.15 USD · —
Jul 3, 2026Teckning
Gustaf Albèrt · Ekonomichef/finanschef/finansdirektör
BTA (betald tecknad aktie) · 202631.0 shares × 1.20 SEK · —
Unfold all 16 remaining filing row(s)
| Transaction date | Published | Filer | Role | Transaction | Instrument | Price (local currency) | Quote currency | Volume | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-03 | 2026-07-06 | Gustaf Albèrt | Ekonomichef/finanschef/finansdirektör | Teckning | Aktie | 1.20 SEK | SEK | 97369.0 | — |
| 2026-07-03 | 2026-07-03 | Jan-Fredrik Backman | Styrelseledamot | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 140716.0 | — |
| 2026-07-03 | 2026-07-03 | Jan-Fredrik Backman | Styrelseledamot | Teckning | Aktie | 1.20 SEK | SEK | 67618.0 | — |
| 2026-07-03 | 2026-07-03 | Jan-Fredrik Wilhelm Backman | Styrelseledamot | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 112573.0 | — |
| 2026-07-03 | 2026-07-03 | Jan-Fredrik Wilhelm Backman | Styrelseledamot | Teckning | Aktie | 1.20 SEK | SEK | 54094.0 | — |
| 2026-07-01 | 2026-07-02 | Carola Elisabet Lemne | Styrelseordförande | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 31000.0 | — |
| 2026-07-01 | 2026-07-02 | Kristina Torfgård | Verkställande direktör (VD) | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 183858.0 | — |
| 2026-07-01 | 2026-07-01 | Joakim Tedroff | Annan medlem i bolagets administrations-, lednings- eller kontrollorgan | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 4016742.0 | — |
| 2026-06-30 | 2026-07-02 | Carola Elisabet Lemne | Styrelseordförande | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 52333.0 | — |
| 2026-06-26 | 2026-06-29 | Nicholas Waters | Annan medlem i bolagets administrations-, lednings- eller kontrollorgan | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 250000.0 | — |
| 2026-06-26 | 2026-06-26 | Kristina Torfgård | Verkställande direktör (VD) | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 66142.0 | — |
| 2026-06-26 | 2026-06-26 | Borkholmen Invest AB | Annan medlem i bolagets administrations-, lednings- eller kontrollorgan | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 427416.0 | — |
| 2026-06-26 | 2026-06-26 | Joakim Tedroff | Annan medlem i bolagets administrations-, lednings- eller kontrollorgan | Teckning | BTA (betald tecknad aktie) | 1.20 SEK | SEK | 555842.0 | — |
| 2025-11-28 | 2025-11-28 | Joakim Tedroff | Annan medlem i bolagets administrations-, lednings- eller kontrollorgan | Förvärv | Aktie | 2.0 SEK | SEK | 250000.0 | — |
| 2025-11-20 | 2025-11-20 | Joakim Tedroff | Annan medlem i bolagets administrations-, lednings- eller kontrollorgan | Förvärv | Aktie | 2.0 SEK | SEK | 70000.0 | — |
| 2025-11-12 | 2025-11-12 | Joakim Tedroff | Annan medlem i bolagets administrations-, lednings- eller kontrollorgan | Förvärv | Aktie | 2.40 SEK | SEK | 50000.0 | — |
Showing 19 of 19 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Other disclosed transactions · excluded from score
The underlying filing feed is unavailable in this snapshot; this is not a claim that no filings exist.
Snapshot & identity
- Snapshot date
- 2026-10-18
- Ticker
- IRLAB-A.ST
- ISIN
- SE0029026145
- Sector
- Healthcare
- Industry
- Biotechnology
Company logos by Parqet